This bill matters because it tries to fix a major vulnerability exposed during recent global health crises: the United States' reliance on a limited number of foreign sources for essential medical supplies. If this bill becomes law, the President could actively work to diversify where our medical goods come from, making the supply chain more resilient. This could mean fewer shortages of critical items like masks, ventilators, and specific medications during future pandemics or emergencies, directly impacting public health and national security.

Without this bill, the President would have less direct authority to negotiate these specific types of trade agreements focused solely on medical goods and supply chain resilience. This means the U.S. could remain more susceptible to disruptions in the global medical supply chain, potentially leading to higher prices, longer wait times, or even an inability to access life-saving treatments when demand surges. Voters should care because it addresses a tangible problem that affects everyone's access to healthcare in times of crisis.